Cargando…
A Dose-Response Relationship to Radiotherapy for Cutaneous Lesions of Langerhans Cell Histiocytosis
Langerhans cell histiocytosis (LCH) is a rare disease, afflicting approximately 4.6 and 1-2 per 1 million children and adults, respectively. While LCH can involve numerous organ systems such as the lung or bone, it is uncommon for the disease to be limited to the skin. Radiotherapy has an establishe...
Autores principales: | Farrugia, Mark K., Morrison, Carl, Hernandez-Ilizaliturri, Francisco, Aljabab, Saif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016594/ https://www.ncbi.nlm.nih.gov/pubmed/33833885 http://dx.doi.org/10.1155/2021/6680635 |
Ejemplares similares
-
Langerhans Cell Histiocytosis of the Cranial Base: Is Low-Dose Radiotherapy Effective?
por: Meyer, Andreas, et al.
Publicado: (2012) -
Radiotherapy for Langerhans Cell Histiocytosis of Bilateral Eyelids
por: Leveson, James, et al.
Publicado: (2016) -
Cytological diagnosis of Langerhans cell histiocytosis with cutaneous involvement
por: Chandekar, Sushama A, et al.
Publicado: (2013) -
Langerhans' cell histiocytosis with neurological injuries diagnosed
from a single cutaneous lesion
por: Bannach, Andréa Bauer, et al.
Publicado: (2017) -
Optimal Therapy for Adults with Langerhans Cell Histiocytosis Bone Lesions
por: Cantu, Maria A., et al.
Publicado: (2012)